UNSPSC 51263160: Cicloprolol hydrochloride

This classification denotes the hydrochloride form of a beta-adrenergic blocking agent with the molecular formula C18H29NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1K2ACH4U3R, chemically known as 2-propanol, 1-(4-(2-(cyclopropylmethoxy)ethoxy)phenoxy)-3-((1-methylethyl)amino)- but more generally known as cicloprolol, which bears US NIH Compound Identifier 146294. European Medicines Agency schedules Cicloprolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06248MIG.

UNSPSC 51263160 Cicloprolol hydrochloride is a Commodity code that does not reflect the work actually being solicited under it in recent state and local procurement activity. The two recent opportunities tagged to this code — Seminole County, Florida's IFB for naloxone and drug deactivation systems, and the Texas Health and Human Services Commission's RFI on direct-to-manufacturer prescription programs — involve pharmaceutical procurement and pharmacy benefit management but are unrelated to cicloprolol hydrochloride, a beta-blocker used in cardiovascular treatment. The code shows little relevant recent activity aligned with its nominal pharmaceutical scope.

The mismatch between the code designation and actual solicitation content suggests either a data-entry error in the tagging of these opportunities or a fundamental misalignment in how this commodity code has been applied in the state and local procurement system. No additional opportunities appear in the recent record to establish a pattern of use or to characterize the issuing-body mix, geographic spread, or actual demand for cicloprolol hydrochloride at the state and local level.